Gut microbes and metabolic disorders- dissection of the underlying preventive and causal mechanisms and development of personalized dietary treatment strategies

Description of the granted funding

Metabolic disorders (MDs) including non-alcoholic fatty liver disease (NAFLD) are major health problems. We will use commensal gut microbes to elucidate the mechanisms that affect host metabolic health both at organism and molecular level. This knowledge is needed to further understand the role of specific diets and therapeutic use of bacteria for prevention/treatment of MDs. Specifically, we will confirm the disease-causing/preventive role of the specific gut microbes, elucidate the underlying pathologic mechanisms for the development of effective treatment strategies, combine data collected from human diets, gut microbiota composition, and in vitro studies to identify specific dietary compounds that affect the abundance of the harmful and beneficial microbes, to treat/prevent MDs in animal models and humans targeting the abundance harmful and beneficial microbes by specific diets.
Show more

Starting year

2017

End year

2022

Granted funding

Satu Pekkala Orcid -palvelun logo
434 485 €

Related funding decisions

335802
Research costs of Academy Research Fellows(2020)
199 847 €
314212
Research costs of Academy Research Fellows(2017)
328 629 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Other information

Funding decision number

308042

Fields of science

Plant biology, microbiology, virology

Research fields

Mikrobiologia

Identified topics

diabetes, medicine, metabolic diseases